台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    65.0
  • 漲跌
    ▼2.3
  • 漲幅
    -3.42%
  • 成交量
    434
  • 產業
    上櫃 生技醫療類股
  • 73人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
易威 (1799)籌碼相關-華南永昌-古亭 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw06/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1001/2202/1402/2803/1203/2404/0604/1604/2805/0805/10405060708090Jul '24Sep '24Nov '24Mar '25May '2560d90dAll

華南永昌-古亭 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/05/0800.00166.1067.30-1491-0.20%
2025/05/0700.00164.7065.90-1481-0.21%
2025/04/2900.00162.5062.50-1464-0.22%
2025/04/2400.001556.5056.50-15467-3.21%
2025/04/15160.2000.0060.1014900.20%
2025/04/11159.2000.0059.2014930.20%
2025/03/14177.70278.5077.70-1617-0.16%
2025/03/11283.10280.7081.5005570.00%
2025/03/1000.00176.8076.80-1518-0.19%
2025/02/20170.70170.1071.0004970.00%
2025/01/17158.6000.0058.6016160.16%
2024/12/3000.00168.9066.70-1692-0.14%
2024/12/2500.00273.4574.00-2683-0.29%
2024/12/2300.00264.5066.40-2680-0.29%
2024/12/20260.9500.0060.4026840.29%
2024/12/19563.16166.0062.7046950.58%
2024/12/1800.00160.9060.90-1678-0.15%
2024/12/16454.7300.0054.5046790.59%
2024/12/1300.00153.8054.90-1678-0.15%
2024/12/1200.00155.3054.90-1678-0.15%
2024/12/11155.0000.0054.9016660.15%
2024/11/2000.00167.6067.40-1666-0.15%
2024/11/1500.00165.6066.00-1678-0.15%
2024/11/14168.50166.0069.0006700.00%
2024/11/13163.1000.0064.0016520.15%
2024/11/12163.80170.1070.0006320.00%
2024/11/11270.1500.0070.1026060.33%
2024/11/08384.2700.0077.8036030.50%
2024/11/07185.2000.0086.1016200.16%
2024/10/181112.0000.00110.0017680.13%
2024/10/1400.001115.50121.00-1817-0.12%
2024/10/091113.5000.00119.0018380.12%
2024/10/0800.002125.75126.00-2839-0.24%
2024/10/071113.501117.00116.5008300.00%
2024/10/01197.2000.0097.2017870.13%
2024/09/276120.0000.00120.0067960.75%
2024/09/265135.4000.00133.0057850.64%
2024/09/255153.3000.00147.5057840.64%
2024/09/2400.001170.00159.00-1789-0.13%
2024/09/232156.2500.00158.0027940.25%
2024/09/201169.0000.00169.0017820.13%
2024/09/191168.501174.00177.0007850.00%
2024/09/131178.5000.00178.0017790.13%
2024/09/101185.5000.00183.0018120.12%
2024/09/091185.001196.00195.0008080.00%
2024/09/061198.0000.00195.0018000.12%
2024/09/041207.001207.00207.0008020.00%
2024/09/0300.001222.00217.00-1797-0.13%
2024/08/271221.0000.00220.0017850.13%
2024/08/220.1224.5000.00221.500.17980.01%
2024/08/201215.002212.75216.00-1806-0.12%
2024/08/1600.001196.50200.50-1822-0.12%
2024/08/1500.000.7192.77191.50-0.7827-0.08%
2024/08/132191.2500.00189.0028430.24%
2024/08/1200.005203.50198.00-5835-0.60%
2024/08/096199.173199.69203.5038240.36%
2024/08/072174.0100.00180.0027810.26%
2024/08/061173.0000.00171.0017770.13%
2024/08/051169.503172.50180.00-2768-0.26%
2024/08/021175.0000.00177.5017490.13%
2024/08/0100.001175.50175.50-1732-0.14%
2024/07/3100.001162.00161.00-1727-0.14%
2024/07/3000.002150.00148.00-2716-0.28%
2024/07/293141.5000.00141.5037080.42%
2024/07/231161.0000.00160.0016850.15%
2024/07/190185.0000.00182.0006500.00%
2024/07/1700.001191.00191.00-1589-0.17%
2024/07/1600.002168.75174.50-2566-0.35%
2024/07/151159.5000.00164.5015540.18%
2024/07/041126.0000.00126.0014770.21%
2024/07/033125.0000.00124.5034740.63%
2024/06/281118.503125.67130.00-2413-0.48%
2024/06/272116.2500.00118.5023930.51%
2024/06/261107.0000.00108.0013780.26%
2024/06/1100.001100.00101.50-1324-0.31%
2024/06/05196.5000.0098.6013150.32%
2024/05/21390.5700.0093.0032501.20%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音